Description
Provider of healthcare services intended to offer cardiovascular treatment. The company's services are focused on the treatment of heart and other related diseases with advanced therapeutic methods, enabling patients to get efficient treatment for their diseases and recover faster.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Secondary Transaction - Private | 01-Jan-2020 | Completed | Startup | |||
1. Early Stage VC (Series A) | 30-Apr-2014 | Completed | Startup |
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20170095291-A1 | Aorticorenal ganglion detection | Abandoned | 06-Oct-2015 | 00000000000 | 00 |
US-20180177549-A1 | Aorticorenal ganglion detection | Abandoned | 06-Oct-2015 | 00000000000 | 0 |
EP-3397334-A1 | Aorticorenal ganglion detection | Withdrawn | 06-Oct-2015 | 00000000000 | |
EP-3397334-A4 | Aorticorenal ganglion detection | Withdrawn | 06-Oct-2015 | A61B18/1492 | 0 |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Douglas Harrington | Founder, Chief Executive Officer & President |